Telomir Pharmaceuticals (TELO) Stock Chart & Stock Price History $4.75 -0.23 (-4.62%) Closing price 01/23/2025 04:00 PM EasternExtended Trading$4.90 +0.16 (+3.26%) As of 08:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Telomir Pharmaceuticals Stock Price Performance 5 Day Performance+1.28%1 Month Performance-4.43%3 Month Performance+12.83%6 Month Performance+16.71%Year-To-Date Performance+15.29% Receive TELO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address TELO Stock Chart for Friday, January, 24, 2025 TELO Chart by TradingView Telomir Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/23/2025$4.98$4.75-4.62%$5.01$4.6753,674 shs$140.65 million01/22/2025$4.93$4.98+1.01%$5.15$4.8372,201 shs$147.46 million01/21/2025$4.69$4.93+5.12%$5.00$4.6263,197 shs$145.98 million01/20/2025$4.69$4.69$4.94$4.6148,910 shs$138.87 million01/17/2025$4.79$4.69-2.09%$4.94$4.6148,910 shs$138.87 million01/16/2025$4.84$4.79-1.03%$5.17$4.7378,288 shs$141.83 million01/15/2025$4.58$4.84+5.68%$4.90$4.5590,755 shs$143.31 million01/14/2025$4.50$4.58+1.78%$4.70$4.4144,219 shs$135.61 million01/13/2025$4.11$4.50+9.49%$4.86$4.14223,538 shs$133.25 million01/10/2025$4.30$4.11-4.42%$4.48$4.05226,250 shs$121.70 million Get the Latest News and Ratings for TELO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 01/09/2025$4.30$4.30$4.58$4.2891,320 shs$127.32 million01/08/2025$4.55$4.30-5.49%$4.58$4.2891,320 shs$127.32 million01/07/2025$4.23$4.55+7.57%$4.86$4.33187,106 shs$134.73 million01/06/2025$4.52$4.23-6.42%$4.62$4.23126,705 shs$125.25 million01/03/2025$4.07$4.52+11.06%$4.66$4.04103,878 shs$133.84 million01/02/2025$4.12$4.07-1.21%$4.35$4.0185,030 shs$120.51 million01/01/2025$4.12$4.12$4.77$4.02286,014 shs$121.99 million12/31/2024$4.64$4.12-11.21%$4.77$4.02286,014 shs$121.99 million12/30/2024$4.87$4.64-4.72%$4.82$4.50145,810 shs$137.39 million12/27/2024$4.81$4.87+1.25%$5.11$4.66206,793 shs$144.20 million12/26/2024$4.97$4.81-3.22%$5.16$4.6883,657 shs$142.42 million12/25/2024$4.97$4.97$5.34$4.69106,708 shs$147.16 million12/24/2024$4.66$4.97+6.65%$5.34$4.69106,708 shs$147.16 million12/23/2024$5.18$4.66-10.04%$5.07$4.62185,317 shs$137.98 million Related Companies Altimmune Stock Price Chart ProKidney Stock Price Chart Mind Medicine (MindMed) Stock Price Chart Stoke Therapeutics Stock Price Chart Arcturus Therapeutics Stock Price Chart Cartesian Therapeutics Stock Price Chart Mineralys Therapeutics Stock Price Chart Verve Therapeutics Stock Price Chart MeiraGTx Stock Price Chart Sage Therapeutics Stock Price Chart Receive TELO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TELO) was last updated on 1/24/2025 by MarketBeat.com Staff From Our PartnersVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredJUST RELEASED: HUGE NEW A.I. TRADEI’ve traded every major tech boom since the dawn of the personal computer. And I can tell you one thing wit...The Oxford Club | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredLegendary Investor: “Buy These “Trump Stocks Now”Within the first week of Trump's election, several stocks exploded for double- and triple-digit gains. Acco...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telomir Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
